Notice of Results
GENinCode Plc will release its audited final results for the year ended 31 December 2025 on Monday, 8 June 2026, followed by an analyst briefing at 09:30 BST. The company's Chief Executive Officer and Chief Financial Officer will then host a live investor presentation on Wednesday, 10 June at 11:00 BST via the Investor Meet Company platform, allowing existing and potential shareholders to submit questions.
Select text to share a quote on X · sign in to keep highlights & notes in your GENI notes
Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer, announces that it will release its audited final results for the year ended 31 December 2025 on Monday, 8 June 2026.
Analyst briefing
A briefing open to equity research analysts will take place on Monday 8 June 2026 at 09.30am BST. To register and for more details please contact Walbrook PR on genincode@walbrookpr.com.
Investor presentation
Matthew Walls, Chief Executive Officer, and Paul Foulger, Chief Financial Officer, will provide a live presentation relating to the results via the Investor Meet Company platform on Wednesday, 10 June at 11am BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet GENinCode here. Investors who already follow GENinCode on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.